![]()
Nucleotide Sequences
QTLs in Region (GRCr8)
RGD ID | Symbol | Name | LOD | P Value | Trait | Sub Trait | Chr | Start | Stop | Species | 631561 | Hcuc2 | Hepatic copper content QTL 2 | 2.8 | liver copper amount (VT:0003065) | liver total copper weight (CMO:0001507) | 16 | 1 | 39533949 | Rat | 1582235 | Insul8 | Insulin level QTL 8 | 3.3 | 0.0063 | blood insulin amount (VT:0001560) | calculated serum insulin level (CMO:0000359) | 16 | 1 | 26727669 | Rat | 70215 | Niddm29 | Non-insulin dependent diabetes mellitus QTL 29 | 3.54 | blood glucose amount (VT:0000188) | blood glucose level area under curve (AUC) (CMO:0000350) | 16 | 19004435 | 75226532 | Rat | 2307172 | Activ4 | Activity QTL 4 | 3.71 | 0.00023 | locomotor behavior trait (VT:0001392) | number of entries into a discrete space in an experimental apparatus (CMO:0000960) | 16 | 1 | 33418960 | Rat | 1354584 | Despr6 | Despair related QTL 6 | 3.1 | 0.0067 | locomotor behavior trait (VT:0001392) | amount of time spent in voluntary immobility (CMO:0001043) | 16 | 1 | 39533930 | Rat | 2302380 | Slep6 | Serum leptin concentration QTL 6 | 3.36 | blood leptin amount (VT:0005667) | serum leptin level (CMO:0000780) | 16 | 1 | 32139025 | Rat | 737819 | Hcas4 | Hepatocarcinoma susceptibility QTL 4 | 4.43 | liver integrity trait (VT:0010547) | volume of individual liver tumorous lesion (CMO:0001078) | 16 | 4227609 | 46975965 | Rat | 9590151 | Scort8 | Serum corticosterone level QTL 8 | 8.45 | 0.001 | blood corticosterone amount (VT:0005345) | plasma corticosterone level (CMO:0001173) | 16 | 1 | 30836262 | Rat | 1354625 | Despr7 | Despair related QTL 7 | 3.16 | 0.016 | locomotor behavior trait (VT:0001392) | amount of time spent in voluntary immobility (CMO:0001043) | 16 | 1 | 44977551 | Rat | 61338 | Bp23 | Blood pressure QTL 23 | 4.3 | arterial blood pressure trait (VT:2000000) | systolic blood pressure (CMO:0000004) | 16 | 4227609 | 49227609 | Rat | 61405 | Niddm6 | Non-insulin dependent diabetes mellitus QTL 6 | 3.66 | 0.001 | blood glucose amount (VT:0000188) | plasma glucose level (CMO:0000042) | 16 | 4227609 | 48972724 | Rat | 631830 | Alc7 | Alcohol consumption QTL 7 | 2.9 | consumption behavior trait (VT:0002069) | ethanol drink intake rate (CMO:0001407) | 16 | 1 | 26727669 | Rat | 7411664 | Foco30 | Food consumption QTL 30 | 11 | 0.001 | eating behavior trait (VT:0001431) | feed conversion ratio (CMO:0001312) | 16 | 1 | 44588133 | Rat | 1600378 | Arunc4 | Aerobic running capacity QTL 4 | 0.03 | exercise endurance trait (VT:0002332) | maximum distance run on treadmill (CMO:0001406) | 16 | 380245 | 80345693 | Rat | 70183 | BpQTLcluster13 | Blood pressure QTL cluster 13 | 3.654 | arterial blood pressure trait (VT:2000000) | mean arterial blood pressure (CMO:0000009) | 16 | 4227609 | 43025077 | Rat | 1600369 | Hcas8 | Hepatocarcinoma susceptibility QTL 8 | liver integrity trait (VT:0010547) | liver tumorous lesion number (CMO:0001068) | 16 | 1 | 22477621 | Rat | 737826 | Alc11 | Alcohol consumption QTL 11 | 3.2 | consumption behavior trait (VT:0002069) | ethanol drink intake rate (CMO:0001407) | 16 | 4227609 | 60252231 | Rat | 2303566 | Bw90 | Body weight QTL 90 | 2 | body mass (VT:0001259) | body weight (CMO:0000012) | 16 | 1 | 39533930 | Rat | 2312663 | Slep9 | Serum leptin concentration QTL 9 | 0.001 | blood leptin amount (VT:0005667) | serum leptin level (CMO:0000780) | 16 | 832236 | 59492508 | Rat | 2306902 | Bp339 | Blood pressure QTL 339 | 0.01 | arterial blood pressure trait (VT:2000000) | systolic blood pressure (CMO:0000004) | 16 | 3380150 | 43025077 | Rat | 1300133 | Rf24 | Renal function QTL 24 | 3.64 | blood creatinine amount (VT:0005328) | creatinine clearance (CMO:0000765) | 16 | 3380150 | 21361552 | Rat | 2312660 | Bw95 | Body weight QTL 95 | 0.05 | inguinal fat pad mass (VT:0010424) | inguinal fat pad weight to body weight ratio (CMO:0001253) | 16 | 832236 | 59492508 | Rat | 2312666 | Insul16 | Insulin level QTL 16 | 0.01 | blood insulin amount (VT:0001560) | serum insulin level (CMO:0000358) | 16 | 832236 | 59492508 | Rat | 634355 | Rends4 | Renal damage susceptibility QTL 4 | 0.05 | kidney blood vessel morphology trait (VT:0000530) | organ lesion measurement (CMO:0000677) | 16 | 1 | 26727669 | Rat | 70205 | Gcr3 | Gastric cancer resistance QTL 3 | 2.3 | stomach morphology trait (VT:0000470) | stomach tumor diameter (CMO:0001889) | 16 | 17696791 | 82635055 | Rat | 2293343 | Glom16 | Glomerulus QTL 16 | 7.4 | kidney glomerulus integrity trait (VT:0010546) | kidney sclerotic glomeruli count to total glomeruli count ratio (CMO:0001269) | 16 | 832236 | 46053497 | Rat | 6903319 | Bw114 | Body weight QTL 114 | 2.7 | 0.0037 | body mass (VT:0001259) | body weight (CMO:0000012) | 16 | 1 | 43534949 | Rat | 2312669 | Stl23 | Serum triglyceride level QTL 23 | 0.01 | blood triglyceride amount (VT:0002644) | serum triglyceride level (CMO:0000360) | 16 | 832236 | 59492508 | Rat | 631561 | Hcuc2 | Hepatic copper content QTL 2 | 2.8 | liver copper amount (VT:0003065) | liver total copper weight (CMO:0001507) | 16 | 1 | 39533949 | Rat | 8552962 | Pigfal16 | Plasma insulin-like growth factor 1 level QTL 16 | 9.4 | blood insulin-like growth factor amount (VT:0010479) | plasma insulin-like growth factor 1 level (CMO:0001299) | 6 | 1 | 41223769 | Rat | 1582235 | Insul8 | Insulin level QTL 8 | 3.3 | 0.0063 | blood insulin amount (VT:0001560) | calculated serum insulin level (CMO:0000359) | 16 | 1 | 26727669 | Rat | 8693632 | Alc27 | Alcohol consumption QTL 27 | 2.2 | 0.791 | drinking behavior trait (VT:0001422) | calculated ethanol drink intake rate (CMO:0001615) | 6 | 34323357 | 51121479 | Rat | 10401812 | Kidm54 | Kidney mass QTL 54 | kidney mass (VT:0002707) | both kidneys wet weight (CMO:0000085) | 6 | 14368788 | 59368788 | Rat | 2302380 | Slep6 | Serum leptin concentration QTL 6 | 3.36 | blood leptin amount (VT:0005667) | serum leptin level (CMO:0000780) | 16 | 1 | 32139025 | Rat | 737819 | Hcas4 | Hepatocarcinoma susceptibility QTL 4 | 4.43 | liver integrity trait (VT:0010547) | volume of individual liver tumorous lesion (CMO:0001078) | 16 | 4227609 | 46975965 | Rat | 9590151 | Scort8 | Serum corticosterone level QTL 8 | 8.45 | 0.001 | blood corticosterone amount (VT:0005345) | plasma corticosterone level (CMO:0001173) | 16 | 1 | 30836262 | Rat | 1354625 | Despr7 | Despair related QTL 7 | 3.16 | 0.016 | locomotor behavior trait (VT:0001392) | amount of time spent in voluntary immobility (CMO:0001043) | 16 | 1 | 44977551 | Rat | 10401800 | Kidm49 | Kidney mass QTL 49 | kidney mass (VT:0002707) | both kidneys wet weight (CMO:0000085) | 6 | 14368788 | 59368788 | Rat | 61338 | Bp23 | Blood pressure QTL 23 | 4.3 | arterial blood pressure trait (VT:2000000) | systolic blood pressure (CMO:0000004) | 16 | 4227609 | 49227609 | Rat | 9589129 | Insul24 | Insulin level QTL 24 | 19.06 | 0.001 | blood insulin amount (VT:0001560) | plasma insulin level (CMO:0000342) | 6 | 1 | 41223769 | Rat | 1354632 | Scl29 | Serum cholesterol level QTL 29 | 3.74 | blood cholesterol amount (VT:0000180) | serum total cholesterol level (CMO:0000363) | 6 | 35098709 | 71636405 | Rat | 1578758 | Tcas9 | Tongue tumor susceptibility QTL 9 | 3.29 | tongue integrity trait (VT:0010553) | number of squamous cell tumors of the tongue with diameter greater than 3 mm (CMO:0001950) | 6 | 1 | 37618905 | Rat | 631830 | Alc7 | Alcohol consumption QTL 7 | 2.9 | consumption behavior trait (VT:0002069) | ethanol drink intake rate (CMO:0001407) | 16 | 1 | 26727669 | Rat | 7411664 | Foco30 | Food consumption QTL 30 | 11 | 0.001 | eating behavior trait (VT:0001431) | feed conversion ratio (CMO:0001312) | 16 | 1 | 44588133 | Rat | 70183 | BpQTLcluster13 | Blood pressure QTL cluster 13 | 3.654 | arterial blood pressure trait (VT:2000000) | mean arterial blood pressure (CMO:0000009) | 16 | 4227609 | 43025077 | Rat | 7411542 | Bw127 | Body weight QTL 127 | 5.5 | 0.001 | body mass (VT:0001259) | body weight gain (CMO:0000420) | 6 | 1 | 41223769 | Rat | 737826 | Alc11 | Alcohol consumption QTL 11 | 3.2 | consumption behavior trait (VT:0002069) | ethanol drink intake rate (CMO:0001407) | 16 | 4227609 | 60252231 | Rat | 9589048 | Scfw3 | Subcutaneous fat weight QTL 3 | 4.57 | 0.001 | subcutaneous adipose mass (VT:1000472) | abdominal subcutaneous fat pad weight (CMO:0002069) | 6 | 1 | 41223769 | Rat | 2293650 | Bss31 | Bone structure and strength QTL 31 | 5.05 | 0.0001 | femur strength trait (VT:0010010) | femur midshaft polar moment of inertia (CMO:0001669) | 6 | 1 | 42487980 | Rat | 1578665 | Bss16 | Bone structure and strength QTL 16 | 4.4 | femur morphology trait (VT:0000559) | bone trabecular cross-sectional area (CMO:0002311) | 6 | 11735669 | 72593685 | Rat | 1641898 | Colcr4 | Colorectal carcinoma resistance QTL4 | 3.71 | 0.0007 | intestine integrity trait (VT:0010554) | well differentiated malignant colorectal tumor surface area measurement (CMO:0002077) | 6 | 20338777 | 62613667 | Rat | 1578668 | Bmd14 | Bone mineral density QTL 14 | 3.8 | femur mineral mass (VT:0010011) | total volumetric bone mineral density (CMO:0001728) | 6 | 11735669 | 72593685 | Rat | 1300133 | Rf24 | Renal function QTL 24 | 3.64 | blood creatinine amount (VT:0005328) | creatinine clearance (CMO:0000765) | 16 | 3380150 | 21361552 | Rat | 70199 | Coreg1 | Compensatory renal growth QTL 1 | 11.8 | kidney mass (VT:0002707) | compensatory renal growth score (CMO:0001894) | 6 | 35691618 | 57730540 | Rat | 2301972 | Bp325 | Blood pressure QTL 325 | 4.8 | arterial blood pressure trait (VT:2000000) | systolic blood pressure (CMO:0000004) | 6 | 1 | 72227641 | Rat | 2293656 | Bss28 | Bone structure and strength QTL 28 | 6.79 | 0.0001 | femur morphology trait (VT:0000559) | femur midshaft cortical cross-sectional area (CMO:0001663) | 6 | 1 | 42487980 | Rat | 70205 | Gcr3 | Gastric cancer resistance QTL 3 | 2.3 | stomach morphology trait (VT:0000470) | stomach tumor diameter (CMO:0001889) | 16 | 17696791 | 82635055 | Rat | 1354664 | Slep2 | Serum leptin concentration QTL 2 | 4.49 | blood leptin amount (VT:0005667) | serum leptin level (CMO:0000780) | 6 | 16536140 | 71636405 | Rat | 1300143 | Rf14 | Renal function QTL 14 | 2.92 | renal blood flow trait (VT:2000006) | absolute change in renal blood flow rate (CMO:0001168) | 6 | 34434137 | 77102317 | Rat | 70215 | Niddm29 | Non-insulin dependent diabetes mellitus QTL 29 | 3.54 | blood glucose amount (VT:0000188) | blood glucose level area under curve (AUC) (CMO:0000350) | 16 | 19004435 | 75226532 | Rat | 2307172 | Activ4 | Activity QTL 4 | 3.71 | 0.00023 | locomotor behavior trait (VT:0001392) | number of entries into a discrete space in an experimental apparatus (CMO:0000960) | 16 | 1 | 33418960 | Rat | 634318 | Bw118 | Body weight QTL 118 | 3.55 | abdominal fat pad mass (VT:1000711) | abdominal fat pad weight (CMO:0000088) | 6 | 33309549 | 57730294 | Rat | 634307 | Bp141 | Blood pressure QTL 141 | 4 | arterial blood pressure trait (VT:2000000) | systolic blood pressure (CMO:0000004) | 6 | 35230417 | 80230417 | Rat | 1354584 | Despr6 | Despair related QTL 6 | 3.1 | 0.0067 | locomotor behavior trait (VT:0001392) | amount of time spent in voluntary immobility (CMO:0001043) | 16 | 1 | 39533930 | Rat | 2292589 | Emca10 | Estrogen-induced mammary cancer QTL 10 | 0.048 | mammary gland integrity trait (VT:0010552) | post-insult time to mammary tumor formation (CMO:0000345) | 6 | 16536140 | 61536140 | Rat | 1300164 | Rf15 | Renal function QTL 15 | 3.12 | renal blood flow trait (VT:2000006) | absolute change in renal blood flow rate (CMO:0001168) | 6 | 5074497 | 54641141 | Rat | 1331779 | Rf38 | Renal function QTL 38 | 2.876 | kidney blood vessel physiology trait (VT:0100012) | absolute change in renal vascular resistance (CMO:0001900) | 6 | 32074428 | 72227641 | Rat | 61405 | Niddm6 | Non-insulin dependent diabetes mellitus QTL 6 | 3.66 | 0.001 | blood glucose amount (VT:0000188) | plasma glucose level (CMO:0000042) | 16 | 4227609 | 48972724 | Rat | 4145119 | Mcs25 | Mammary carcinoma susceptibility QTL 25 | 0.0001 | mammary gland integrity trait (VT:0010552) | ratio of deaths to total study population during a period of time (CMO:0001023) | 6 | 10894415 | 110548006 | Rat | 1600378 | Arunc4 | Aerobic running capacity QTL 4 | 0.03 | exercise endurance trait (VT:0002332) | maximum distance run on treadmill (CMO:0001406) | 16 | 380245 | 80345693 | Rat | 7411603 | Foco13 | Food consumption QTL 13 | 5.5 | 0.001 | eating behavior trait (VT:0001431) | feed conversion ratio (CMO:0001312) | 6 | 1 | 41223769 | Rat | 1598843 | Cm63 | Cardiac mass QTL 63 | 2.6 | heart mass (VT:0007028) | heart weight to body weight ratio (CMO:0000074) | 6 | 1 | 39036266 | Rat | 738024 | Sach5 | Saccharine consumption QTL 5 | 3.9 | 0.00039 | consumption behavior trait (VT:0002069) | saccharin intake volume to total fluid intake volume ratio (CMO:0001601) | 6 | 1 | 43394190 | Rat | 1600369 | Hcas8 | Hepatocarcinoma susceptibility QTL 8 | liver integrity trait (VT:0010547) | liver tumorous lesion number (CMO:0001068) | 16 | 1 | 22477621 | Rat | 2293839 | Kiddil2 | Kidney dilation QTL 2 | 4.8 | kidney pelvis morphology trait (VT:0004194) | hydronephrosis severity score (CMO:0001208) | 6 | 20866422 | 81133036 | Rat | 2303566 | Bw90 | Body weight QTL 90 | 2 | body mass (VT:0001259) | body weight (CMO:0000012) | 16 | 1 | 39533930 | Rat | 1576309 | Emca7 | Estrogen-induced mammary cancer QTL 7 | 4 | mammary gland integrity trait (VT:0010552) | mammary tumor number (CMO:0000343) | 6 | 15107216 | 107351382 | Rat | 2293709 | Bss23 | Bone structure and strength QTL 23 | 5.18 | 0.0001 | femur morphology trait (VT:0000559) | femur cross-sectional area (CMO:0001661) | 6 | 1 | 42487980 | Rat | 7411584 | Foco4 | Food consumption QTL 4 | 4.3 | 0.001 | eating behavior trait (VT:0001431) | feed conversion ratio (CMO:0001312) | 6 | 1 | 42838846 | Rat | 2293841 | Kiddil4 | Kidney dilation QTL 4 | 4.4 | kidney pelvis morphology trait (VT:0004194) | hydronephrosis severity score (CMO:0001208) | 6 | 20866422 | 81133036 | Rat | 2312663 | Slep9 | Serum leptin concentration QTL 9 | 0.001 | blood leptin amount (VT:0005667) | serum leptin level (CMO:0000780) | 16 | 832236 | 59492508 | Rat | 2306902 | Bp339 | Blood pressure QTL 339 | 0.01 | arterial blood pressure trait (VT:2000000) | systolic blood pressure (CMO:0000004) | 16 | 3380150 | 43025077 | Rat | 6893340 | Cm77 | Cardiac mass QTL 77 | 0.26 | 0.57 | heart mass (VT:0007028) | heart weight to body weight ratio (CMO:0000074) | 6 | 33309549 | 81132889 | Rat | 2312660 | Bw95 | Body weight QTL 95 | 0.05 | inguinal fat pad mass (VT:0010424) | inguinal fat pad weight to body weight ratio (CMO:0001253) | 16 | 832236 | 59492508 | Rat | 2312666 | Insul16 | Insulin level QTL 16 | 0.01 | blood insulin amount (VT:0001560) | serum insulin level (CMO:0000358) | 16 | 832236 | 59492508 | Rat | 634355 | Rends4 | Renal damage susceptibility QTL 4 | 0.05 | kidney blood vessel morphology trait (VT:0000530) | organ lesion measurement (CMO:0000677) | 16 | 1 | 26727669 | Rat | 2293343 | Glom16 | Glomerulus QTL 16 | 7.4 | kidney glomerulus integrity trait (VT:0010546) | kidney sclerotic glomeruli count to total glomeruli count ratio (CMO:0001269) | 16 | 832236 | 46053497 | Rat | 6903319 | Bw114 | Body weight QTL 114 | 2.7 | 0.0037 | body mass (VT:0001259) | body weight (CMO:0000012) | 16 | 1 | 43534949 | Rat | 2312669 | Stl23 | Serum triglyceride level QTL 23 | 0.01 | blood triglyceride amount (VT:0002644) | serum triglyceride level (CMO:0000360) | 16 | 832236 | 59492508 | Rat | |
Additional Information